Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: BI 836826 Dose Escalation in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) [Phase 1]
A Phase 1 dose-escalation trial of BI 836826 in patients with relapsed or refractory non-Hodgkin lymphoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas. [Phase 2]
Phase 2 trial update for an oral LY317615 in relapsed or refractory diffuse large B-cell lymphoma, with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-28Clinical Trial Update: MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell Origin [Phase 1, Phase 2]
Clinical trial update for MG4101 plus rituximab with lymphodepletion in relapsed/refractory non-Hodgkin lymphoma (B-cell origin) spanning Ph…
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating autologous peripheral stem cell transplant in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma has comple…
-
CLINICAL_TRIALS trial_result · 2020-07-08Clinical Trial Update: Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas [Phase 2]
Phase 2 clinical trial assessing chemotherapy plus ofatumumab followed by G-CSF for mobilizing peripheral blood stem cells in patients with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-06-26Clinical Trial Update: P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies [Phase 3]
Phase 3 trial of umbilical cord blood cells expanded with MPCs for transplantation in hematologic malignancies has completed.
-
FDA approval · 2020-06-26FDA Approved: CYTARABINE — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approval of Meitheal Pharmaceuticals' original ANDA for Cytarabine (cytarabine), a generic injectable anticancer agent.
-
CLINICAL_TRIALS trial_result · 2020-06-02Clinical Trial Update: Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger [Phase 2]
Phase 2 trial comparing Rituximab-HCVAD alternating with Rituximab-Methotrexate-Cytarabine vs Rituximab-CHOP in newly diagnosed high-risk ag…
-
CLINICAL_TRIALS trial_result · 2020-05-18Clinical Trial Update: Meloxicam vs Placebo for Mobilization [Phase 2]
Phase 2 trial comparing Meloxicam to placebo for mobilization in hematologic malignancies has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-11Clinical Trial Update: Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating lenalidomide with rituximab in non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 safety and tolerability study of PCI-32765 in various B-cell malignancies completed; results posted.
-
FDA approval · 2020-05-05FDA Approved: RITUXAN HYCELA — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for Rituxan HYCELA (rituximab and hyaluronidase) from Genentech, expanding its approval through …
-
CLINICAL_TRIALS trial_result · 2020-04-29Clinical Trial Update: A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants [Phase 1, Phase 2]
Phase 1/2 study of idasanutlin in combination with obinutuzumab for relapsed/refractory follicular lymphoma and with rituximab for relapsed/…
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR [NA]
Clinical trial update on donor-derived humoral immunity and hematopoietic stem cell transplantation completed with posted results in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL) [Phase 1]
Phase 1 study of ADCT-402 in relapsed or refractory B-cell lineage non-Hodgkin lymphoma completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment [Phase 2]
Phase 2 trial update of combination chemotherapy in Hodgkin's disease or non-Hodgkin lymphoma not responding to prior treatment.
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: Chidamide in Combination With Decitabine in Non-Hodgkin's Lymphoma Relapsed After Chimeric Antigen Receptor [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating chidamide in combination with decitabine for relapsed/refractory non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide [Phase 1, Phase 2]
Phase I/II study evaluating bendamustine in combination with ofatumumab, carboplatin, and etoposide in non-Hodgkin lymphoma has completed wi…
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab [Phase 1]
Phase 1 study of PF-05082566 as a single agent and with rituximab in various lymphomas; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial of PNT2258 in relapsed or refractory non-Hodgkin's lymphoma completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
Clinical trial update on polatuzumab vedotin in combination with standard chemoimmunotherapy in B-cell non-Hodgkin's lymphoma (Phase 1/2) co…
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma [Phase 1]
Phase 1 trial update on leukemia/lymphoma patients using LMP-specific T-cells for relapsed EBV-positive lymphoma; results posted for a compl…
-
FDA approval · 2020-01-30FDA Approved: METHOTREXATE — Original Application (Chartwell RX, LLC)
FDA approvedChartwell RX, LLC's methotrexate product under an Original Application, making a new generic version of methotrexate available. …
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Study of CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T) in ALL and NHL [Phase 1, Phase 2]
Clinical trial update on CD19 CAR-T therapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts [Phase 2]
A Phase 2 clinical trial evaluating T cell depletion in recipients of HLA haploidentical related donor stem cell grafts for various hematolo…